BioLineRx Ltd. (TLV:BLRX)

BioLineRx Revenue

BioLineRx had revenue of $294.00K USD in the quarter ending June 30, 2026, a decrease of -3.29%. This brings the company's total for the last twelve months to $1.39M, down -91.93% year-over-year. In the year 2025, BioLineRx had annual revenue of $1.18M, down -95.92%. That makes BioLineRx the 43,126th largest company in the world by revenue and 429th in Israel.

• Revenue (ttm): $1.39M
• Revenue Growth: -91.93%
• P/S Ratio: 7.92
• Revenue / Employee: $58.00K
• Employees: 24
• Market Cap: 32.86M ILS

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• China 14.96M 51.7%
• U.s. 13.98M 48.3%

Fiscal year ended Dec 31, 2024 See the full BioLineRx breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.18M	-27.76M	-95.92%
Dec 31, 2024	28.94M	24.14M	502.92%
Dec 31, 2023	4.80M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error